UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 26, 2014
STAAR Surgical
Company
(Exact name of registrant as specified in its charter)
|
Delaware of incorporation) |
0-11634 (Commission File Number) |
95-3797439 Identification No.) |
| 1911 Walker Ave, Monrovia, California (Address of principal executive offices) | 91016 (Zip Code) |
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On September 26, 2014, Ms. Kathryn Tunstall submitted her resignation as a director of STAAR Surgical Company (the “ Company ”), to be effective immediately, in order to attend to her health issues. Ms. Tunstall’s resignation was not submitted as the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| September 29, 2014 | By: /s/ Barry G. Caldwell |
| Barry G. Caldwell | |
| President and Chief Executive Officer |